Chris Winchester is a strategic communications specialist who enjoys developing global medical communication programmes on behalf of pharmaceutical and biotechnology companies, professional societies and patient groups.
He is Chief Executive Officer of the independent HealthScience communications consultancy Oxford PharmaGenesis, which has offices in Oxford, London, Cardiff, Basel, Melbourne and Philadelphia. Oxford PharmaGenesis received a Queen’s Award for Enterprise in 2015, won a Communiqué Award for Excellence in Corporate Social Responsibility in 2016, and was ‘Highly Commended’ in the Communiqué Medical Education Consultancy of the Year category in 2018.
He has conducted research on the value of professional medical writing support and clinical trials transparency (ORCID ID: orcid.org/0000-0003-3267-3990) and chaired the Board of Trustees of the International Society for Medical Publication Professionals (2018–2019). Chris completed a BA and DPhil in Biochemistry at the University of Oxford, and is a member of Green Templeton College, Oxford. In his spare time, Chris plays double-bass in the Newbury Symphony Orchestra.